These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32996241)

  • 21. Identification and characterization of a Streptococcus suis immunogenic ornithine carbamoytransferase involved in bacterial adherence.
    Wang Y; Yi L; Sun LY; Liu YC; Wen WY; Li XK; Mei JJ; Ding K; Wu TC; Grenier D
    J Microbiol Immunol Infect; 2020 Apr; 53(2):234-239. PubMed ID: 29934035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the immune response and evaluation of the protective capacity of rSsnA against Streptococcus suis infection in pigs.
    Gómez-Gascón L; Cardoso-Toset F; Tarradas C; Gómez-Laguna J; Maldonado A; Nielsen J; Olaya-Abril A; Rodríguez-Ortega MJ; Luque I
    Comp Immunol Microbiol Infect Dis; 2016 Aug; 47():52-9. PubMed ID: 27477507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enolase and dipeptidyl peptidase IV protein sub-unit vaccines are not protective against a lethal Streptococcus suis serotype 2 challenge in a mouse model of infection.
    Dumesnil A; Martelet L; Grenier D; Auger JP; Harel J; Nadeau E; Gottschalk M
    BMC Vet Res; 2019 Dec; 15(1):448. PubMed ID: 31823789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of IgA1 protease as a surface protective antigen of Streptococcus suis serotype 2.
    Fu L; Zhao J; Lin L; Zhang Q; Xu Z; Han L; Xie C; Zhou R; Jin M; Zhang A
    Microbes Infect; 2016 Apr; 18(4):285-9. PubMed ID: 26774332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9.
    Jiang X; Yang Y; Zhu L; Gu Y; Shen H; Shan Y; Li X; Wu J; Fang W
    Vaccine; 2016 Dec; 34(51):6529-6538. PubMed ID: 27349838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and immunological evaluation of elongation factor Tu of Streptococcus suis serotype 2.
    Xia XJ; Wang L; Cheng LK; Shen ZQ; Li SG; Wang JL
    Pol J Vet Sci; 2017 Mar; 20(2):277-284. PubMed ID: 28865219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine.
    Wisselink HJ; Vecht U; Stockhofe-Zurwieden N; Smith HE
    Vet Rec; 2001 Apr; 148(15):473-7. PubMed ID: 11334073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide analysis of an avirulent strain that induces protective immunity against challenge with virulent Streptococcus suis serotype 2.
    Wang J; Feng Y; Wang C; Zheng F; Hassan B; Zhi L; Li W; Yao Y; He E; Jiang S; Tang J
    BMC Microbiol; 2017 Mar; 17(1):67. PubMed ID: 28292261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First insights into the protective effects of a recombinant swinepox virus expressing truncated MRP of Streptococcus suis type 2 in mice.
    Huang D; Zhu H; Lin H; Xu J; Lu C
    Berl Munch Tierarztl Wochenschr; 2012; 125(3-4):144-52. PubMed ID: 22515033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy.
    Büttner N; Beineke A; de Buhr N; Lilienthal S; Merkel J; Waldmann KH; Valentin-Weigand P; Baums CG
    Vet Immunol Immunopathol; 2012 May; 146(3-4):191-200. PubMed ID: 22516423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9.
    Baums CG; Kock C; Beineke A; Bennecke K; Goethe R; Schröder C; Waldmann KH; Valentin-Weigand P
    Clin Vaccine Immunol; 2009 Feb; 16(2):200-8. PubMed ID: 19109449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of a Streptococcus suis vaccine composed of six conserved immunogens.
    Weiße C; Dittmar D; Jakóbczak B; Florian V; Schütze N; Alber G; Klose K; Michalik S; Valentin-Weigand P; Völker U; Baums CG
    Vet Res; 2021 Aug; 52(1):112. PubMed ID: 34433500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live-attenuated Salmonella enterica serotype Choleraesuis vaccine with regulated delayed fur mutation confer protection against Streptococcus suis in mice.
    Li YA; Chen Y; Du YZ; Guo W; Chu D; Fan J; Wang X; Bellefleur M; Wang S; Shi H
    BMC Vet Res; 2020 May; 16(1):129. PubMed ID: 32381017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection.
    Garibaldi M; Rodríguez-Ortega MJ; Mandanici F; Cardaci A; Midiri A; Papasergi S; Gambadoro O; Cavallari V; Teti G; Beninati C
    Vaccine; 2010 Apr; 28(20):3609-16. PubMed ID: 20079873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetically modified suilysin, rSLY(P353L), provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis.
    Du H; Huang W; Xie H; Ye C; Jing H; Ren Z; Xu J
    Vaccine; 2013 Aug; 31(38):4209-15. PubMed ID: 23856333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.
    Kock C; Beineke A; Seitz M; Ganter M; Waldmann KH; Valentin-Weigand P; Baums CG
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):135-45. PubMed ID: 19505730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and Study of Bacterins.
    Doan TD; Wu HC; Chu CY
    Methods Mol Biol; 2024; 2815():131-142. PubMed ID: 38884916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from
    Goyette-Desjardins G; Auger JP; Dolbec D; Vinogradov E; Okura M; Takamatsu D; Van Calsteren MR; Gottschalk M; Segura M
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747605
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the immunoprotective effects of IF-2 GTPase and SSU05-1022 as a candidate for a
    Chen T; Wang C; Hu L; Lu H; Song F; Zhang A; Wang X; Chen H; Tan C
    Future Microbiol; 2021 Jul; 16():721-729. PubMed ID: 34223787
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2.
    Wisselink HJ; Stockhofe-Zurwieden N; Hilgers LA; Smith HE
    Vet Microbiol; 2002 Jan; 84(1-2):155-68. PubMed ID: 11731168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.